PMA P150003S060

Device
Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System
Applicant
Boston Scientific Corporation
PMA number
P150003
Supplement
S060
Product code
NIQ
Decision date
2020-04-09
Generic name
Coronary drug-eluting stent
Approval order statement
Changes to the mechanism used to crimp the stent to its final profile.

Current openFDA PMA Record#

Device
Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System
Applicant
Boston Scientific Corporation
PMA number
P150003
Supplement
S060
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2020-04-09
Decision code
OK30
Date received
2020-03-13
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Changes to the mechanism used to crimp the stent to its final profile.